In work that has moved from the lab to the clinic and back, and is now poised to enter the clinic yet again, researchers have figured out how to manufacture and administer what they believe is the first highly effective malaria vaccine – one that can provide protection lasting at least six to 24 months to 80 percent of those vaccinated.